Search results
Results From The WOW.Com Content Network
This is an accepted version of this page This is the latest accepted revision, reviewed on 9 February 2025. Administration of a vaccine to protect against disease This article is about administration of a vaccine. For the vaccines themselves, see vaccine. See also: Immunization Medical intervention Vaccinations Girl about to be vaccinated in her upper arm ICD-9-CM 99.3 - 99.5 [edit on Wikidata ...
Yellow fever vaccine is a vaccine that protects against yellow fever. [4] Yellow fever is a viral infection that occurs in Africa and South America. [4] Most people begin to develop immunity within ten days of vaccination and 99% are protected within one month, and this appears to be lifelong. [4]
Vaccines may be monovalent (also called univalent) or multivalent (also called polyvalent). A monovalent vaccine is designed to immunize against a single antigen or single microorganism. [82] A multivalent or polyvalent vaccine is designed to immunize against two or more strains of the same microorganism, or against two or more microorganisms. [83]
A hexavalent vaccine, or 6-in-1 vaccine, is a combination vaccine with six individual vaccines conjugated into one, intended to protect people from multiple diseases. [1] [9] The term usually refers to the children's vaccine that protects against diphtheria, tetanus, pertussis, poliomyelitis, haemophilus B, and hepatitis B, [1] [9] which is used in more than 90 countries around the world ...
The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea. ... is a single-dose vaccine. It works by using a modified virus to produce ...
Vaccination against vaccine-preventable diseases is a major relief of disease burden even though it usually cannot eradicate a disease. Vaccines against microorganisms that cause diseases can prepare the body's immune system, thus helping to fight or prevent an infection.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
In January 2020, the US Food and Drug Administration (FDA) approved Audenz as a vaccine for the H5N1 flu virus. [265] Audenz is a vaccine indicated for active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine. Audenz is approved for use in persons six months of age and older at ...